{
  "core_info": {
    "core_event_name": "华熙生物反击“玻尿酸过气论”",
    "update_time": "更新至20250908",
    "sub_event_count": 0,
    "scrape_time": "2025-09-12 14:42:15"
  },
  "sub_events": [
    {
      "id": "event_1",
      "title": "百人团队裁减至十几人?华熙生物陷入裁员与业绩之困",
      "link": "http://finance.eastmoney.com/a/202509083507655948.html",
      "time": "9月8日 16:57",
      "summary": "",
      "author": ""
    },
    {
      "id": "event_2",
      "title": "“玻尿酸帝国”华熙生物的痛:应收账款高企,核心业务萎缩",
      "link": "http://finance.sina.cn/2025-09-08/detail-infptvcq9892378.d.html",
      "time": "9月8日 08:21",
      "summary": "",
      "author": ""
    },
    {
      "id": "event_3",
      "title": "华熙生物上半年营收净利润均下滑 二季度净利润率有所上升",
      "link": "http://finance.youth.cn/finance_gdxw/202509/t20250906_16220442.htm",
      "time": "9月6日 14:18",
      "summary": "",
      "author": ""
    },
    {
      "id": "event_4",
      "title": "华熙生物反击“玻尿酸过气论”",
      "link": "http://stock.stockstar.com/IG2025090400013635.shtml",
      "time": "9月4日 11:03",
      "summary": "",
      "author": ""
    }
  ],
  "total_sub_events": 4,
  "scrape_time": "2025-09-12 14:42:29"
}